This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Apr;205(4):1098-1099.

doi: 10.1097/JU.0000000000001567.01. Epub 2021 Jan 25.

Editorial Comment

Nathan Perlis¹

Affiliations

Affiliation

¹ Urologic Oncology, Sprott Department of Surgery, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada.

PMID: 33487010
DOI: 10.1097/JU.0000000000001567.01

Comment

Editorial Comment

Nathan Perlis. J Urol. 2021 Apr.

. 2021 Apr;205(4):1098-1099.

doi: 10.1097/JU.0000000000001567.01. Epub 2021 Jan 25.

Author

Nathan Perlis¹

Affiliation

¹ Urologic Oncology, Sprott Department of Surgery, Princess Margaret Cancer Center, University Health Network, University of Toronto, Toronto, Ontario, Canada.

PMID: 33487010
DOI: 10.1097/JU.0000000000001567.01

No abstract available

PubMed Disclaimer

Comment on

Prostate Radiofrequency Focal Ablation (ProRAFT) Trial: A Prospective Development Study Evaluating a Bipolar Radiofrequency Device to Treat Prostate Cancer.
Orczyk C, Barratt D, Brew-Graves C, Peng Hu Y, Freeman A, McCartan N, Potyka I, Ramachandran N, Rodell R, Williams NR, Emberton M, Ahmed HU. Orczyk C, et al. J Urol. 2021 Apr;205(4):1090-1099. doi: 10.1097/JU.0000000000001567. Epub 2020 Dec 14. J Urol. 2021. PMID: 33315505 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations